Cardiology News

Findings from the SUMMIT trial demonstrated that the long-acting GLP-1/GIP receptor agonist tirzepatide reduced risk for cardiovascular death or worsening heart failure by 38% vs. placebo in adults with HF with preserved ejection fraction and obesity.

Hypertension, atrial fibrillation and smoking were most strongly associated with an increased risk for severe compared with non-severe stroke, according to analysis from the INTERSTROKE study.

CHICAGO — People living in historically redlined neighborhoods with poor access to healthy foods were more likely to have type 2 diabetes, hypertension, coronary heart disease and obesity, researchers reported.

CHICAGO — An intensive blood pressure strategy resulted in a lower incidence of major cardiovascular events compared with a more standard strategy among patients with type 2 diabetes and elevated systolic blood pressure in the BPROAD trial.

CHICAGO — The rate of deaths from CVD increased in rural areas and decreased in urban areas of the U.S. from 2010 to 2022, and the difference was especially pronounced amid the COVID-19 pandemic and among younger adults, researchers reported.

Children with normal blood pressure may not need BP screenings as often as current recommendations call for, according to a longitudinal study published in JAMA Pediatrics.

Most lipid-lowering medications lack safety data for pregnant and lactating women, complicating management of hyperlipidemia and hypertriglyceridemia, but data suggest statins can be used for those at high risk for cardiovascular events.

Older Chinese adults with hearing, visual or dual sensory impairment had higher risk for CVD compared with those without sensory impairment, according to a study published in the Journal of the American Heart Association.

In part one of a three-part Healio exclusive series, experts discussed the need for clinical guidance and evidence for the use of AI to improve cardiovascular outcomes.